McMahon Publishing Infectious Disease Special Edition

Share

PRINT EMAIL FACEBOOK TWITTER LINKEDIN GOOGLE+ NEW ORLEANS—Telavancin, a once-daily, injectable lipoglycopeptide antibiotic, has shown success in combating difficult-to-treat pathogens, according to in vitro data from two new studies presented at the ASM Microbe 2017 meeting. The research found that telavancin (Vibativ, Theravance Biopharma) was...

Intravascular devices (IVDs) include peripheral vascular catheters (venous and arterial), pulmonary artery ... was an accurate predictor for CRBSIs in studies of short- and long-term devices. 18,28-30 Now, newer diagnostic techniques such as real-time ...

“These findings, coupled with the cost savings involved with using cefazolin over nafcillin, make it an appealing first-line agent for most MSSA bloodstream infections,” said Dr. Monogue. In vivo experiments suggested that high-density MSSA ...